Thiotepa trials for Sickle cell disease

All Thiotepa trials · All Sickle cell disease trials

Phase breakdown

Recruiting trials studying Thiotepa for Sickle cell disease

• Haploidentical Donor Hematopoietic Cell Transplant for Sickle Cell Disease
  NCT07616154 · Phase: Phase 2 · Ages: Up to 22 Years · Sex: All (male and female) · 1 location
• Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT
  NCT01962415 · Phase: Phase 2 · Ages: 2 Months to 55 Years · Sex: All (male and female) · 2 locations
• T-Cell Depleted Alternative Donor Bone Marrow Transplant for Sickle Cell Disease (SCD) and Other Anemias
  NCT03653338 · Phase: Phase 1, Phase 2 · Ages: 5 Years to 40 Years · Sex: All (male and female) · 1 location

Common questions

How many trials study Thiotepa for Sickle cell disease?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.